Cardiomyopathy associated with the use of anabolic androgenic steroids. Case report

• Main Authors: Kristina V. Charaya (Author), Tamerlan N. Erdniev (Author), Galina D. Makarenko (Author), Maria I. Chashkina (Author), Nana A. Gogiberidze (Author), Anait Sh. Dumikyan (Author), Dmitry Yu. Shchekochikhin (Author), Petr Sh. Chomakhidze (Author), Maria G. Poltavskaya (Author), Denis A. Andreev (Author)
• Format: Book
• Published: ZAO "Consilium Medicum", 2024-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The use of anabolic androgenic steroids (AAS) in supraphysiologic doses is associated with a number of adverse effects on the cardiovascular system. In the presented clinical case, a bodybuilder athlete abusing AAS developed heart failure with a decrease in left ventricular ejection fraction of up t...